by Stacey Johnson | Jan 27, 2017
Epidermolysis bullosa (EB) is a rare, and exceedingly painful, skin condition that I’ve written about here and here. Children with EB are sometimes referred to as “butterfly children” because their skin is said to be as fragile as a butterfly’s wings. The severity of...
by Camila Londono | Jan 11, 2017
Brain drain was a real problem for Canada in the late ‘90s. A study by Statistics Canada found that twice as many post-secondary professors and teachers went to the United States than came to Canada in that period. This untenable situation—in which education and...
by Sara M. Nolte | Dec 5, 2016
On November 15th, my social media pages exploded with posts and comments regarding the latest news about how the gene-editing ‘CRISPR-Cas9’ technology had been used in the first human patient. The article, published by Nature, was entitled “CRISPR gene-editing tested...
by Stacey Johnson | Nov 9, 2016
This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature...
by Lisa Willemse | Sep 30, 2016
There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these...
by Holly Wobma | Sep 22, 2016
If you have been following stem cell news lately, you know that there have been several recent Food and Drug Administration (FDA) meetings regarding how to classify stem cells, which ultimately affects if and how they will be regulated. There are many medical...
Comments